Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.62 |
| ▸ | MMP1 | P03956 | 9/20 | 0.62 |
| ▸ | MMP9 | P14780 | 8/20 | 0.62 |
| ▸ | MMP8 | P22894 | 8/20 | 0.62 |
| ▸ | NMBR | P28336 | 2/20 | 0.61 |
| ▸ | MMP14 | P50281 | 3/20 | 0.61 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.61 |
| ▸ | ADAM12 | O43184 | 1/20 | 0.61 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.61 |
| ▸ | MMP3 | P08254 | 1/20 | 0.61 |
| ▸ | MMP7 | P09237 | 1/20 | 0.61 |
| ▸ | MMP12 | P39900 | 1/20 | 0.61 |
| ▸ | MMP13 | P45452 | 1/20 | 0.61 |
| ▸ | MMP15 | P51511 | 1/20 | 0.61 |
| ▸ | MMP16 | P51512 | 1/20 | 0.61 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.61 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.61 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.61 |
| ▸ | MMP17 | Q9ULZ9 | 1/20 | 0.61 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8019332 | 0.87 | NMBR (0.71) | MMP2MMP1MMP9MMP8NMBR | |
| SCHEMBL641549 | 0.85 | CCKBR (0.70) | MMP2MMP1MMP9MMP8MMP14 | |
| SCHEMBL1373082 | 0.85 | CCKBR (0.63) | MMP2MMP1MMP9MMP8MMP14 | |
| SCHEMBL6020214 | 0.84 | NMBR (0.60) | NMBR | |
| SCHEMBL4612012 | 0.83 | KCNA5 (0.63) | NMBR | |
| SCHEMBL8547809 | 0.83 | KMT2A (0.66) | NMBR | |
| SCHEMBL3820631 | 0.83 | KCNA5 (0.63) | NMBR | |
| SCHEMBL8785114 | 0.83 | KCNA5 (0.63) | NMBR | |
| SCHEMBL6413828 | 0.82 | MMP2 (0.68) | MMP2MMP1MMP9MMP8MMP14 | |
| SCHEMBL6020516 | 0.81 | CTSL (0.72) | MMP2MMP1MMP8NMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957112-A2 | ROLE OF PROTEOGLYCANS IN DRUG DEPENDENCE | Sanna, Pietro Paolo (US) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007062048-A2 | ROLE OF PROTEOGLYCANS IN DRUG DEPENDENCE | SCRIPPS RESEARCH INST (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-1399466-A2 | COMPOUNDS AND METHODS FOR THE MODULATION OF CD154 | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002089730-A2 | COMPOUNDS AND METHODS FOR THE MODULATION OF CD154 | THE CENTER FOR BLOOD RESEARCH, INC. (US) | 2002-11-14 | — | — | WO | disclosed |